Advanced search
Publication Cover
Current Medical Research and Opinion Volume 20, 2004 - Issue 1
Submit an article Journal homepage
142
Views
26
CrossRef citations to date
0
Altmetric
Research Article

Insulin glargine: long-acting basal insulin analog for improved metabolic control

John E. Gerich School of Medicine and Dentistry, University of Rochester, NY, USACorrespondence[email protected]
Pages 31-37 | Published online: 22 Sep 2008

Citations (26)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Bridget R Levich. (2011) Diabetes management: optimizing roles for nurses in insulin initiation. Journal of Multidisciplinary Healthcare 4, pages 15-24.
Read now
Rosalind Fabunmi, Loretta L. Nielsen, Ralph Quimbo, Brock Schroeder, Derek Misurski, Matthew Wintle & Ron Wade. (2009) Patient characteristics, drug adherence patterns, and hypoglycemia costs for patients with type 2 diabetes mellitus newly initiated on exenatide or insulin glargine. Current Medical Research and Opinion 25:3, pages 777-786.
Read now

Articles from other publishers (24)

Kai‐Jen Tien, Yi‐Jen Hung, Jung‐Fu Chen, Ching‐Chu Chen, Chih‐Yuan Wang, Chii‐Min Hwu, Yu‐Yao Huang, Pi‐Jung Hsiao, Shih‐Te Tu, Chao‐Hung Wang & Wayne Huey‐Herng Sheu. (2019) Basal insulin therapy: Unmet medical needs in Asia and the new insulin glargine in diabetes treatment. Journal of Diabetes Investigation 10:3, pages 560-570.
Crossref
Maria Yu, Kate Van Brunt, Zvonko Milicevic, Oralee Varnado & Kristina S. Boye. (2017) Patient-reported Outcomes in Patients with Type 2 Diabetes Treated with Dulaglutide Added to Titrated Insulin Glargine (AWARD-9). Clinical Therapeutics 39:11, pages 2284-2295.
Crossref
Danny D Meetoo. (2016) Insulin: An evolving paradigm in diabetes management. Practice Nursing 27:Sup3, pages 11-16.
Crossref
Danny D Meetoo. (2013) Insulin: an evolving paradigm in diabetes management. British Journal of Healthcare Management 19:Sup1, pages 8-15.
Crossref
Danny MeetooGillian McAllister, Adele West & Mandy Turnbull. (2012) In pursuit of excellence in diabetes care: trends in insulin delivery. British Journal of Nursing 21:10, pages 588-595.
Crossref
Arshag D. Mooradian. (2011) Special Considerations with Insulin Therapy in Older Adults with Diabetes Mellitus. Drugs & Aging 28:6, pages 429-438.
Crossref
Monika Lechleitner & Friedrich Hoppichler. (2011) Insulin therapyInsulintherapie. Wiener Medizinische Wochenschrift 161:11-12, pages 300-304.
Crossref
Jutta M. Nagel, Jürgen Staffa, Ingrid Renner-Müller, David Horst, Michael Vogeser, Markus Langkamp, Andreas Hoeflich, Burkhard Göke, Frank T. Kolligs & Christos S. Mantzoros. (2010) Insulin Glargine and NPH Insulin Increase to a Similar Degree Epithelial Cell Proliferation and Aberrant Crypt Foci Formation in Colons of Diabetic Mice. Hormones and Cancer 1:6, pages 320-330.
Crossref
A. Agin & R. Sapin. (2010) Analogues et dosages d’insuline : le cas général et le cas particulier de la glargine. Médecine Nucléaire 34:10, pages 571-582.
Crossref
Derek Misurski, Maureen J. Lage, Rosalind Fabunmi & Kristina S. Boye. (2012) A comparison of costs among patients with type 2 diabetes mellitus who initiated therapy with exenatide or insulin glargine. Applied Health Economics and Health Policy 7:4, pages 245-254.
Crossref
Scott Drab. (2009) Translating clinical guidelines into clinical practice: Role of the pharmacist in type 2 diabetes management. Journal of the American Pharmacists Association 49:6, pages e152-e162.
Crossref
M. Yenigun & M. Honka. (2009) Switching patients from insulin glargine-based basal-bolus regimens to a once daily insulin detemir-based basal-bolus regimen: results from a subgroup of the PREDICTIVE™ study. International Journal of Clinical Practice 63:3, pages 425-432.
Crossref
Guillermo E. Umpierrez, Tiffany Hor, Dawn Smiley, Angel Temponi, Denise Umpierrez, Miguel Ceron, Christina Munoz, Christopher Newton, Limin Peng & David Baldwin. (2009) Comparison of Inpatient Insulin Regimens with Detemir plus Aspart Versus Neutral Protamine Hagedorn plus Regular in Medical Patients with Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism 94:2, pages 564-569.
Crossref
Jason Wong, J. Geoffrey Chase, Christopher E. Hann, Geoffrey M. Shaw, Thomas F. Lotz, Jessica Lin & Aaron J. Le Compte. (2008) A Subcutaneous Insulin Pharmacokinetic Model for Computer Simulation in a Diabetes Decision Support Role: Model Structure and Parameter Identification. Journal of Diabetes Science and Technology 2:4, pages 658-671.
Crossref
K. Eckardt, C. May, M. Koenen & J. Eckel. (2007) IGF-1 receptor signalling determines the mitogenic potency of insulin analogues in human smooth muscle cells and fibroblasts. Diabetologia 50:12, pages 2534-2543.
Crossref
Kristina Secnik Boye, Louis S Matza, Alan Oglesby, Karen Malley, Sunny Kim, Risa P Hayes & Robert Brodows. (2006) Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes. Health and Quality of Life Outcomes 4:1.
Crossref
Jonathan S. Bromberg & Derek LeRoith. (2006) Diabetes Cure — Is the Glass Half Full?. New England Journal of Medicine 355:13, pages 1372-1374.
Crossref
A. M. Hennige, T. Sartorius, O. Tschritter, H. Preissl, A. Fritsche, P. Ruth & H.-U. Häring. (2006) Tissue selectivity of insulin detemir action in vivo. Diabetologia 49:6, pages 1274-1282.
Crossref
Geremia B. Bolli. (2006) Insulin Treatment in Type 1 Diabetes. Endocrine Practice 12, pages 105-109.
Crossref
B. Guerci & J.P. Sauvanet. (2005) Subcutaneous insulin: pharmacokinetic variability and glycemic variability. Diabetes & Metabolism 31:4, pages 4S7-4S24.
Crossref
Karen Thibaudeau, Roger Léger, Xicai Huang, Martin Robitaille, Omar Quraishi, Chantal Soucy, Nathalie Bousquet-Gagnon, Pieter van Wyk, Véronique Paradis, Jean-Paul Castaigne & Dominique Bridon. (2005) Synthesis and Evaluation of Insulin−Human Serum Albumin Conjugates. Bioconjugate Chemistry 16:4, pages 1000-1008.
Crossref
R. Hernáez Rodríguez & I. Conget Donlo. (2005) Control glucémico y nuevas perspectivas en la insulinoterapia en la diabetes mellitus de tipo 1. Revista Clínica Española 205:6, pages 290-296.
Crossref
Anita M. Hennige, Rainer Lehmann, Cora Weigert, Klaus Moeschel, Myriam Schäuble, Elisabeth Metzinger, Reiner Lammers & Hans-Ulrich Häring. (2005) Insulin Glulisine. Diabetes 54:2, pages 361-366.
Crossref
Ralph Oiknine, Marla Bernbaum & Arshag D Mooradian. (2005) A Critical Appraisal of the Role of Insulin Analogues in the Management of Diabetes Mellitus. Drugs 65:3, pages 325-340.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.